drugset / Trial / NCT00253266
Venlafaxine Augmentation in Treatment Resistant Depression
RandomizedParallel-groupTriple-blindTreatment
Summary
This is an assessment of the efficacy of venlafaxine-HCL augmentation with the neuroleptic quetiapine in treatment resistant depression.
Timeline
- Start
- 2008-04
- Primary completion
- 2014-04
- Completion
- 2014-08
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | Quetiapine | Small molecule | 200 mg | — |
| Background | Venlafaxine | Small molecule | 450 mg | — |